DK0559145T3 - Lægemiddel til truende abort - Google Patents

Lægemiddel til truende abort

Info

Publication number
DK0559145T3
DK0559145T3 DK93103300T DK93103300T DK0559145T3 DK 0559145 T3 DK0559145 T3 DK 0559145T3 DK 93103300 T DK93103300 T DK 93103300T DK 93103300 T DK93103300 T DK 93103300T DK 0559145 T3 DK0559145 T3 DK 0559145T3
Authority
DK
Denmark
Prior art keywords
abortion
menacing
drug
blood coagulation
human blood
Prior art date
Application number
DK93103300T
Other languages
Danish (da)
English (en)
Inventor
Takaaki Nakaya
Yayoi Kajiwara
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of DK0559145T3 publication Critical patent/DK0559145T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
DK93103300T 1992-03-06 1993-03-02 Lægemiddel til truende abort DK0559145T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP04935392A JP3337488B2 (ja) 1992-03-06 1992-03-06 切迫流産治療剤

Publications (1)

Publication Number Publication Date
DK0559145T3 true DK0559145T3 (da) 2000-04-10

Family

ID=12828657

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93103300T DK0559145T3 (da) 1992-03-06 1993-03-02 Lægemiddel til truende abort

Country Status (11)

Country Link
US (1) US5554593A (de)
EP (1) EP0559145B1 (de)
JP (1) JP3337488B2 (de)
KR (1) KR100255095B1 (de)
AT (1) ATE185274T1 (de)
AU (1) AU657839B2 (de)
CA (1) CA2091134C (de)
DE (1) DE69326627T2 (de)
DK (1) DK0559145T3 (de)
ES (1) ES2138602T3 (de)
GR (1) GR3032224T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69835949D1 (de) * 1997-05-15 2006-11-02 Trillium Therapeutics Inc Verfahren um immunkoagulation zu modulieren
US6642433B1 (en) 1997-05-15 2003-11-04 Trillium Therapeutics Inc. Fgl-2 knockout mice
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US8153162B2 (en) 2005-09-27 2012-04-10 Tissuetech, Inc. Purified amniotic membrane compositions and methods of use
ES2822301T3 (es) 2011-06-10 2021-04-30 Tissuetech Inc Métodos de procesamiento de tejidos de soporte fetal
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
WO2016138025A2 (en) 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
JP2018516869A (ja) 2015-05-20 2018-06-28 ティッシュテック，インク． 上皮細胞の増殖および上皮間葉転換を防ぐための組成物および方法
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
JPH03240738A (ja) * 1990-02-20 1991-10-28 Hoechst Japan Ltd 糖尿病性壊疽治療剤

Also Published As

Publication number Publication date
CA2091134C (en) 2004-04-06
EP0559145A1 (de) 1993-09-08
JP3337488B2 (ja) 2002-10-21
KR100255095B1 (ko) 2000-05-01
DE69326627T2 (de) 2000-02-17
CA2091134A1 (en) 1993-09-07
EP0559145B1 (de) 1999-10-06
US5554593A (en) 1996-09-10
GR3032224T3 (en) 2000-04-27
ATE185274T1 (de) 1999-10-15
KR930019224A (ko) 1993-10-18
ES2138602T3 (es) 2000-01-16
DE69326627D1 (de) 1999-11-11
AU657839B2 (en) 1995-03-23
AU3401093A (en) 1993-09-09
JPH05246886A (ja) 1993-09-24

Similar Documents

Publication Publication Date Title
KR920019342A (ko) 골질환 치료제
DE3382641T2 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
ATE515265T1 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
ATE358505T1 (de) Beschichtete endovaskuläre vorrichtung
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
FI924352A (fi) Jontoforetiskt laekemedels frigoeringssystem
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
DE69327432T2 (de) Heilmittel für wunden und hämorrhoiden
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
PT998287E (pt) Utilizacao de levobupivacaina
DK0559145T3 (da) Lægemiddel til truende abort
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
DE68926746D1 (de) Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
EP0950416A4 (de) Preventiver und/oder therapeutischer Wirkstoffgegen Cachexia
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
ES2077698T3 (es) Agente terapeutico para la gangrena diabetica.
UA30143A (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
DE3877499T2 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
ES2085411T3 (es) Uso de heptastigmina en la terapia de ictus cerebral.
RU96117545A (ru) Способ лечения диабетической ретинопатии
IT7827960A0 (it) Apparecchio fisioterapico a circolazione d'aria per la cura di piaghe, ferite ed affezioni cutanee che traggono beneficio dalla terapia con aria.
ITRM910756A0 (it) Miscela di biofarmaci somministrabile per fleboterapia nel trattamentodelle patologie neuro-psico-somatiche e organico-vascolari, in particolare arteriopatie diabetiche e nicotiniche, cardiopatie ischemiche, tossicodipendenze, psoriasi